Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006 ...

More on SPDR S&P Biotech ETF: Invest In A New Biotech Bull Market With XBI And IBB XBI: Diverse Holding Amid Strong Catalysts, Buy Trump administration cancels $12 billion in funding to state ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter's winners and losers.

The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

The Motley Fool recommends Johnson & Johnson, Moderna, and SPDR Series Trust - SPDR S&P Biotech ETF. The Motley Fool has a disclosure policy.

By Maggie Fick and Bhanvi Satija LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers ...

You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006. An increasingly popular option among retail and institutional investors ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its ...